Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

nasdaq:cytk

POPULAR ARTICLES

NASDAQ:CYTK

pharmaceutical investing

Cytokinetics Starts Phase 2 Clinical Trial for Cardiomyopathy Treatment

pharmaceutical investing

Cytokinetics Announces Start of Phase 2 Clinical Trial of CK-3773274

Cytokinetics and Cure SMA Renew Partnership

LATEST ARTICLES

Cytokinetics Granted European Orphan Designation for Reldesemtiv to Treat Spinal Musclar Atrophy

Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator

Cytokinetics Announces Initiation of Phase 1 Clinical Trial of CK-3773274

pharmaceutical investing

Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program

Latest News

Share Purchase Plan Offer Booklet

Strong Leach Recoveries and Low Impurities

High Grade Cu-Au at Surface Delivers New Targets at Mankayan

Juggernaut Closes $1,100,000 from Institutions and Accredited Investors

Triumph Gold's Executive Chairman Discusses Utah Silver-Gold Acquisition and Exploration Strategy in New INN CEO Insights Interview

Outlook Reports

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Quimbaya Gold

QIM:CC

New Age Exploration

NAE:AU

Asara Resources

AS1:AU

International Lithium Corp.

ILC:CA

Syntheia

SYAI:CC

Sun Summit Minerals

SMN:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES